Glenmark won’t be enjoined in UK from launching generic diabetes drug
MLex Summary: UK High Court Judge Michael Tappin has denied a bid by AstraZeneca AB and AstraZeneca UK Ltd. for an interim injunction that would bar Glenmark Pharmaceuticals Europe from proceeding...To view the full article, register now.
Already a subscriber? Click here to view full article